Vexev Secures $6 Million Funding to Propel FDA Clearance and U.S. Launch of VxWave Robotic Ultrasound Platform

Australian medical robotics company Vexev secures $6 million in funding to expedite FDA 510(k) clearance and U.S. commercialization of VxWave, an AI-powered robotic tomographic ultrasound platform designed to improve access to standardized vascular imaging.